CRISPR Researchers to Benefit from COBO Technologies and SCIEX Partnership
COBO Technologies , a company specialised in quality control services and products in genome editing, today announces a new partnership with SCIEX , a global leader in life science analytical technologies, to develop PIPPR , a unique protein expression analysis platform. Based in Copenhagen, Denmark, Cobo Technologies specialises in products and services for Quality Control of CRISPR-modified cells and animals . The proprietary CRISPR INDEL Profiling Platform (CIPPTM ), which is based on the Indel Detection by Amplicon Analysis (IDAATM ) methodology and developed for detailed DNA mutation analysis, was launched in December 2017, followed by PIPPR, which was launched in January 2019. PIPPR was created for extensive protein/proteome expression profiling using SWATH® Acquisition.
There is an increasing need to do more complexed quality control of cells modified with CRISPR. PIPPR will make it possible to monitor any changes in the protein expression levels in the modified cell. From this data a researcher can easily confirm the quality of any type of CRISPR application and detect potential off-target issues that need to be addressed.
“PIPPR identifies and quantifies proteins of all cells and animals modified with CRISPR and the method doesn’t need any antibodies or labelling of proteins. It’s a fast, sensitive, reproducible and robust solution, but also a cost-effective solution that’ll fit any type of CRISPR application,” says Jens-Ole Bock, CEO and founder of Cobo Technologies. “SCIEX is a world-leading company in mass spectrometry instrumentation and innovative software solutions for proteomics and the pharma industry. Combined with COBO Technologies’ expertise of products and services for quality control of CRISPR applications, you have a very powerful collaboration that’ll benefit scientists as well as the two companies.”
COBO Technologies and SCIEX will promote the PIPPR platform in conjunction with SWATH Acquisition, the TripleTOF® 6600 LC-MS/MS System and related software solutions from SCIEX. COBO Technologies supports customers globally in both research and clinical fields.
PIPPR® is a registered trademark of COBO Technologies. SWATH® and TripleTOF® are registered trademarks of SCIEX.
About COBO Technologies
COBO Technologies is a fast-growing CRO specialised in services and products for quality control of genome editing applications in research and clinical fields. The company supports customers globally with detailed DNA mutation analysis and complexed protein expression profiling of cells, plants or animals modified with genome editing tools such as Meganucleases CRISPR-Cas9, ZFNs and TALENs.
Please visit www.cobotechnologies.com for more detailed information.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com
AB Sciex is operating as SCIEX.
© 2019 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SERVIER14.10.2019 14:02:08 CEST | Press release
Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology
ISL14.10.2019 12:51:06 CEST | Press release
‘Energy’ Pulses Through Superstar Swimmers in International Swimming League Leg in Naples
LIBELIUM14.10.2019 12:42:06 CEST | Press release
Libelium Focuses Its Business on Professional IoT Technology Closing the Electronics Maker Division "Cooking Hacks"
CA-SOTIO14.10.2019 12:10:03 CEST | Press release
PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005
WATERMELON-COMM14.10.2019 10:23:07 CEST | Press release
With Putin’s Visit, UAE Takes Spotlight in the New World Order
METANOIA-COMMUNICATIONS14.10.2019 09:13:09 CEST | Press release
Metanoia Announces Its Next Generation Broadband Access Technology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom